MC
Merck & Co Portfolio holdings
AUM
$216M
This Quarter Return
-15.78%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$258M
AUM Growth
–
Cap. Flow
+$258M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
99.57%
Holding
13
New
13
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Moderna
MRNA
|
$96M |
| 2 |
Personalis
PSNL
|
$81.2M |
| 3 |
Kymera Therapeutics
KYMR
|
$31.1M |
| 4 |
Entrada Therapeutics
TRDA
|
$30.1M |
| 5 |
Alector
ALEC
|
$6.7M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Moderna
MRNA
$9.37B
| $96M | 37.19% |
+2,308,190
| New | +$96M |
|
|
2
Personalis
PSNL
$434M
| $81.2M | 31.46% |
+14,044,943
| New | +$81.2M |
|
|
3
Kymera Therapeutics
KYMR
$2.95B
| $31.1M | 12.04% |
+772,165
| New | +$31.1M |
|
|
4
Entrada Therapeutics
TRDA
$208M
| $30.1M | 11.66% |
+1,739,768
| New | +$30.1M |
|
|
5
Alector
ALEC
$238M
| $6.7M | 2.6% |
+3,545,719
| New | +$6.7M |
|
6
Sutro Biopharma
STRO
$72.7M
| $5.01M | 1.94% |
+2,723,509
| New | +$5.01M |
|
7
Absci
ABSI
$357M
| $2.62M | 1.01% |
+998,163
| New | +$2.62M |
|
8
Viridian Therapeutics
VRDN
$1.5B
| $1.79M | 0.69% |
+93,414
| New | +$1.79M |
|
9
Xilio Therapeutics
XLO
$36.3M
| $1.42M | 0.55% |
+1,483,758
| New | +$1.42M |
|
10
LAVA Therapeutics
LVTX
$41.3M
| $1.09M | 0.42% |
+1,149,345
| New | +$1.09M |
|
11
Carisma Therapeutics
CARM
$8.98M
| $617K | 0.24% |
+1,473,240
| New | +$617K |
|
|
EVAX
12
Evaxion A/S American Depositary Share
EVAX
$17.4M
| $458K | 0.18% |
+542,279
| New | +$458K |
|
|
NEUP
13
Neuphoria Therapeutics Inc. Common Stock
NEUP
$21.3M
| $34.4K | 0.01% |
+10,027
| New | +$34.4K |
|